Volltext verfügbar nach Anmeldung bzw. im Campus-Netz.
Rationale and design of a phase II trial of dacomitinib in advanced non-small cell lung cancer patients with uncommon epidermal growth factor receptor mutations: a prospective and single arm study (DANCE study)
In: BMC Cancer, Jg. 22 (2022-12-01), Heft 1
Online
academicJournal
Zugriff:
Titel: |
Rationale and design of a phase II trial of dacomitinib in advanced non-small cell lung cancer patients with uncommon epidermal growth factor receptor mutations: a prospective and single arm study (DANCE study)
|
---|---|
Autor/in / Beteiligte Person: | Zhang, Bo ; Shi, Chunlei ; Gao, Zhiqiang ; Zhong, Hua ; Xiong, Liwen ; Gu, Aiqin ; Wang, Weimin ; Chu, Tianqing ; Zhang, Wei ; Wang, Huimin ; Zhang, Xueyan ; Zhong, Runbo ; Han, Baohui |
Link: | |
Zeitschrift: | BMC Cancer, Jg. 22 (2022-12-01), Heft 1 |
Veröffentlichung: | 2022 |
Medientyp: | academicJournal |
ISSN: | 1471-2407 (print) |
DOI: | 10.1186/s12885-022-09409-3 |
Sonstiges: |
|